Iréne Areström

460 total citations
17 papers, 355 citations indexed

About

Iréne Areström is a scholar working on Oncology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Iréne Areström has authored 17 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Molecular Biology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Iréne Areström's work include Drug Transport and Resistance Mechanisms (7 papers), Acute Myeloid Leukemia Research (4 papers) and Allergic Rhinitis and Sensitization (3 papers). Iréne Areström is often cited by papers focused on Drug Transport and Resistance Mechanisms (7 papers), Acute Myeloid Leukemia Research (4 papers) and Allergic Rhinitis and Sensitization (3 papers). Iréne Areström collaborates with scholars based in Sweden, United States and Norway. Iréne Areström's co-authors include Niklas Ahlborg, Jacob T. Minang, Marita Troye‐Blomberg, Astrid Gruber, Lena Lundeberg, Sigurd Vitols, Bartek Zuber, Magnus Björkholm, C. Peterson and Holger Luthman and has published in prestigious journals such as PLoS ONE, British Journal of Cancer and British Journal of Haematology.

In The Last Decade

Iréne Areström

17 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Iréne Areström Sweden 10 128 101 91 77 73 17 355
TH. JOOST Netherlands 11 53 0.4× 35 0.3× 281 3.1× 40 0.5× 156 2.1× 15 533
Praneetha Thulasi United States 11 104 0.8× 120 1.2× 29 0.3× 133 1.7× 12 0.2× 25 513
Pedro Ernesto Sánchez‐Hernández Mexico 14 103 0.8× 63 0.6× 21 0.2× 38 0.5× 379 5.2× 27 556
H Gollnick Germany 11 32 0.3× 50 0.5× 156 1.7× 46 0.6× 49 0.7× 32 467
Latanya Benjamin United States 10 43 0.3× 28 0.3× 89 1.0× 17 0.2× 41 0.6× 36 354
R André Switzerland 8 43 0.3× 30 0.3× 61 0.7× 14 0.2× 49 0.7× 63 260
Gerrard J. Perdok Netherlands 9 33 0.3× 239 2.4× 62 0.7× 13 0.2× 93 1.3× 11 558
Michel De La Brassinne Belgium 12 45 0.4× 59 0.6× 131 1.4× 14 0.2× 116 1.6× 43 365
Claus Gattringer Austria 9 158 1.2× 143 1.4× 9 0.1× 81 1.1× 73 1.0× 10 422
Ángel Vera Spain 11 62 0.5× 242 2.4× 108 1.2× 10 0.1× 183 2.5× 20 473

Countries citing papers authored by Iréne Areström

Since Specialization
Citations

This map shows the geographic impact of Iréne Areström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iréne Areström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iréne Areström more than expected).

Fields of papers citing papers by Iréne Areström

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iréne Areström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iréne Areström. The network helps show where Iréne Areström may publish in the future.

Co-authorship network of co-authors of Iréne Areström

This figure shows the co-authorship network connecting the top 25 collaborators of Iréne Areström. A scholar is included among the top collaborators of Iréne Areström based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iréne Areström. Iréne Areström is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Lundberg, M., Hannes Bohman, Sophie Curbo, et al.. (2022). Development of an ELISA displaying similar reactivity with reduced and oxidized human Thioredoxin-1 (Trx1): The plasma level of Trx1 in early onset psychosis disorders. Journal of Immunological Methods. 510. 113347–113347. 1 indexed citations
2.
Areström, Iréne, et al.. (2016). Systematic evaluation of monoclonal antibodies and immunoassays for the detection of Interferon-γ and Interleukin-2 in old and new world non-human primates. Journal of Immunological Methods. 441. 39–48. 5 indexed citations
3.
Lundberg, M., Sophie Curbo, Thomas Masterman, et al.. (2014). Methodological Aspects of ELISA Analysis of Thioredoxin 1 in Human Plasma and Cerebrospinal Fluid. PLoS ONE. 9(7). e103554–e103554. 6 indexed citations
4.
Areström, Iréne, et al.. (2012). Measurement of human latent transforming growth factor-β1 using a latency associated protein-reactive ELISA. Journal of Immunological Methods. 379(1-2). 23–29. 19 indexed citations
5.
Minang, Jacob T., Iréne Areström, & Niklas Ahlborg. (2008). ELISpot Displays a Better Detection over ELISA of T Helper (Th) 2-Type Cytokine-Production byEx Vivo-Stimulated Antigen-Specific T Cells from Human Peripheral Blood. Immunological Investigations. 37(4). 279–291. 5 indexed citations
6.
Minang, Jacob T., Iréne Areström, Bartek Zuber, et al.. (2006). Nickel-induced IL-10 down-regulates Th1- but not Th2-type cytokine responses to the contact allergen nickel. Clinical & Experimental Immunology. 143(3). 494–502. 34 indexed citations
7.
Minang, Jacob T., Iréne Areström, Marita Troye‐Blomberg, Lena Lundeberg, & Niklas Ahlborg. (2006). Nickel, cobalt, chromium, palladium and gold induce a mixed Th1- and Th2-type cytokine responsein vitroin subjects with contact allergy to the respective metals. Clinical & Experimental Immunology. 146(3). 417–426. 86 indexed citations
8.
Areström, Iréne, et al.. (2003). Inclusion of a non-immunoglobulin binding protein in two-site ELISA for quantification of human serum proteins without interference by heterophilic serum antibodies. Journal of Immunological Methods. 283(1-2). 225–234. 34 indexed citations
9.
Mäkitalo, Barbro, Iréne Areström, François Villinger, et al.. (2002). ELISpot and ELISA analysis of spontaneous, mitogen-induced and antigen-specific cytokine production in cynomolgus and rhesus macaques. Journal of Immunological Methods. 270(1). 85–97. 28 indexed citations
10.
11.
Gruber, Astrid, et al.. (1998). Multidrug resistance phenotype in leukaemic cells from patients with acute myelocytic leukaemia can be detected with 99Tcm-MIBI. British Journal of Cancer. 77(11). 1732–1736. 7 indexed citations
12.
Xu, Dawei, Pavel Pisa, Karolina Palucka, et al.. (1996). Levels of mdr1 and mrp mRNA in leukaemic cell populations from patients with acute myelocytic leukaemia are heterogenous and inversely correlated to cellular daunorubicin accumulation. British Journal of Haematology. 92(4). 847–854. 19 indexed citations
13.
Albertioni, Freidoun, Astrid Gruber, Iréne Areström, & Sigurd Vitols. (1995). Multidrug resistance gene (mdr1) RNA levels in relation to P-glycoprotein content of leukemic cells from patients with acute leukemia. Medical Oncology. 12(2). 79–86. 17 indexed citations
14.
Gruber, Astrid, Iréne Areström, Freidoun Albertioni, et al.. (1995). Multidrug Resistance (Mdr1) Gene Expression in Peripheral Blasts from Patients with Acute Leukemia Only Rarely Increases During Disease Progression after Combination Chemotherapy. Leukemia & lymphoma. 18(5-6). 435–442. 5 indexed citations
15.
Gruber, Astrid, et al.. (1993). Effect of verapamil on daunorubicin accumulation in human leukemic cells with different levels of MDR1 gene expression. Leukemia Research. 17(4). 353–358. 9 indexed citations
16.
Gruber, Astrid, Sigurd Vitols, Svante Norgren, et al.. (1992). Quantitative determination of mdr1 gene expression in leukaemic cells from patients with acute leukaemia. British Journal of Cancer. 66(2). 266–272. 52 indexed citations
17.
Gruber, Astrid, Jan Liliemark, Ulf Tidefelt, et al.. (1992). Pharmacokinetics of Mitoxantrone in Plasma and Leukemic Cells During Treatment of Patients with Acute Non-Lymphocytic Leukemia. Leukemia & lymphoma. 6(6). 493–496. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by TH. JOOST Breakdown of academic impact, for papers by Praneetha Thulasi Breakdown of academic impact, for papers by Pedro Ernesto Sánchez‐Hernández Breakdown of academic impact, for papers by H Gollnick Breakdown of academic impact, for papers by Latanya Benjamin Breakdown of academic impact, for papers by R André Breakdown of academic impact, for papers by Gerrard J. Perdok Breakdown of academic impact, for papers by Michel De La Brassinne Breakdown of academic impact, for papers by Claus Gattringer Breakdown of academic impact, for papers by Ángel Vera
Rankless by CCL
2026